chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Could not work for about 24 hours; He was achy; After the second shot, the patient reported a fever; This is a spontaneous report from a non-contactable consumer. A male patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration on 01May2021 as a single dose for COVID-19 immunisation. Medical history, past drug allergy and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration on Apr2021 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Unknown if the patient received any other vaccines within four weeks prior to the vaccination. On 02May2021 after second vaccination, the patient experienced fever and could not work for about 24 hours, was achy and feverish. The clinical outcome of the events could not work for about 24 hours was resolved on 03May2021, while that of events fever and achy was resolved on an unknown date in May2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
VAQTA that had undergone temperature excursion was administered to a patient; No additional AE reported; This spontaneous report was received from an other health professional, referring to a female patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies and concomitant therapies were unknown.     On an unknown date, the patient was vaccinated with hepatitis A vaccine, inactivated (VAQTA) (strength, dose, dose number and route were not provided; lot number U026782 is not valid for hepatitis A vaccine, inactivated (VAQTA) with expiration date reported as 28-OCT-2022) that had undergone temperature excursion for prophylaxis (product storage error). No additional adverse event (AE) reported.       The storage temperature of the vaccine was 49.6 degrees Fahrenheit for a time frame of 32 minutes. There is no previous temperature excursion.
The same night that I got the first dose I had pain in my arm but I also had facial swelling. The swelling was under my eyes and my cheeks. It lasted another whole day. I was prescribed an antihistamine. I had the same facial swelling after the second dose. My face was really puffy after both doses.
developed severe body aches and pain; severe headache; This is a spontaneous report from a non-contactable consumer, the patient. A 56-years-old male patient received first dose of BNT162b2(PFIZER-BIOTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Batch/Lot number: UNKNOWN) via an unspecified route of administration on 22Mar2021 (at the age of 56-year-old) for COVID-19 immunization. The patient medical history was not reported. The patient had no allergies to medications, food, or other products. The patient concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in Mar2021, within 12 hours of receiving the first vaccine, the patient developed severe body aches and pain and also a severe headache. These symptoms were still present 24 hours later. The patient did not receive any treatment for the events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events was severe headache and severe body aches, and pain was not recovered on an unspecified date at the time of this report.    Amendment: This follow-up report is being submitted to amend previously reported information: This is a spontaneous report from a contactable consumer, the patient" updated as "Non-contactable. For both events "developed severe body aches and pain" and "severe headache": Onset updated from "Mar2021" to "22Mar2021" per vaccination date 22Mar2021 and PRD 23Mar2021 and verbatim "These symptoms were still present 24 hours later". Adverse event Within 12 hours of receiving the first vaccine I developed severe body aches and pain. Also, a severe headache. These symptoms were still present 24 hours later. Event occurred in country. And events were not recovered on an unspecified date. The patient didn't receive any treatment.    No follow-up attempts are possible; information about lot/batch number cannot be obtained
Patient reported pain and knots at injection sites.  Patient was administered both Pneumovax and Fluvirin in the left arm seperated by 1 inch.  Patient reported applying warm compress to area for the evening.  Next day one of the injection sites was red and blistered.  Patient presented to pharmacy at 6:00 PM 10/16/2009.  Both injection sites were red but the posterior injection had two dime sized blisterd at the injection site.
Joint pain increased; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ARTHRALGIA (Joint pain increased) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 002A204) for COVID-19 vaccination.     The patient's past medical history included Arthritis. Concurrent medical conditions included Thyroid disorder NOS, Diabetes and Blood pressure. Concomitant products included CARVEDILOL for Blood pressure, METFORMIN for Diabetes, LEVOTHYROXINE for Thyroid disorder NOS, APIXABAN (ELIQUIS) for an unknown indication.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced ARTHRALGIA (Joint pain increased). The patient was treated with PARACETAMOL (TYLENOL) for Joint pain, at an unspecified dose and frequency. At the time of the report, ARTHRALGIA (Joint pain increased) was resolving.     Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: follow-up was received on 08-JUN-2021, event outcome was updated
Lost her vision; Dizzy, lightheaded, lightheadedness; Increased heart rate; A spontaneous report was received from a consumer concerning a 70-years-old female patient who was received Moderna's COVID-19 vaccine (mRNA-1273) and experienced loss of vision, dizziness and increased heart rate.  The patients medical history was not provided. No relevant concomitant medications were reported.  On 28 feb 2021, approximately three days prior to the onset of events loss of vision, dizziness and increased heart rate, the patient received the first of two planned dose of mRNA-1273(Lot number: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On 02 mar 2021, The patient had lost her vision, became dizzy lightheaded, which led to an increased heart rate. The patient still had intermittent lightheadedness. The event loss of vision was medically significant. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the events loss of vision, dizziness and increased heart rate was not provided.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
14may90 pt vax hepta B. pt devel arthralgia and myalgia.  concominant med included sudafed, actifed, lotrimin.
One day and a few hours after my 2nd dose of covid vaccine, my  blood sugar dropped to 40 before I was able to check it and drink orange juice to raise the level to 100. About 30 minutes after my sugar had gone to 100, it fell again to 42. Prior to this event at 10:30 pm, I had eaten a big meal of 3 fried eggs, 4 pieces of bacon and 4 pieces of toast at 9:45 pm. I can only attribute this event of the sugar dropping to the effect of the vaccine.  Both the 1st and 2nd vaccine has set my Myasthenia Gravis exaberation of weakness into a very bad situation for me. I am extremely weak from the vaccine. The 1st on was taken on May 13th and I have been weak since and the second on just compounded the weakness.
Fever up to 104 and swollen lymph nodes still 9 days after vaccine headache chills
37 yo G2P1001 at 19w6d  (EDC of 11/5/22 by IVF dates) presents 13 days after Moderna Booster Vaccine #3) with fetal demise. Pregnancy followed for IVF, hypertension on amlodipine, subclinical hypothyroidism. At 12 wks gestation, she underwent chorionic villous sampling due to prior affected child with X Linked SLC6A8 condition with normal microarray.
Post vaccination, the client exhibited symptoms of lethargy.  The patient was pale, dry, normal temperature but unresponsive upon initial assessment. BP 130, good radial pulses, SpO2 98%.  The patient started responding 5 minutes later as we activate emergency and slowly became more alert with better muscle tone.  At arrival of emergency, the patient as interactive and shivering.  Vital signs normal.  Released to care of mother.
Immediately after injection pt's arm turned red and swelled. 5 wks later pt c/o continuing pain and unable to raise arm (abduct).
After receiving the MMR, Varicella, and Pneumococcal vaccines all on the same day (1/11/19), patient ran a fever all day on 1/20/19. However, she was still active and showed no other symptoms. We treated her fever throughout the day by alternating between ibuprofen and TYLENOL. By 11:15pm, patient's temperature had reached 103, and she had a febrile seizure. Her body went stiff and her eyes rolled to the side. She stayed this way for several seconds before coming out of it, and then she vomited. 911 was called. Patient was taken to the ER that night and then seen by a doctor at her pediatrician's office the next day, and this doctor confirmed that all of this was a side effect of the MMR, which was not explained to us prior to the administration of the vaccine. Now that she has had this febrile seizure, patient is at increased risk for future seizures and epilepsy.
Subject in pneumococcal vaccine trial, with severe COPD was hospitalized w/ left eye pain d/t cataract. Vaccination took place 3/25/09. According to physician the relationship is 'None'.
Headache; Lymph node swelling; Aches in neck and left arm-pit; Aches in neck and left arm-pit; General 'grogginess'; Administration date 10Nov2021, dose number=3; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF8841) via an intramuscular route of administration in the left arm on 10Nov2021 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had known allergies to walnuts. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EJ1685) via an intramuscular route of administration in the left arm on 03Mar2021 (at the age of 35-years-old) and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EK5730) via an intramuscular route of administration in the left arm on 24Mar2021 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. On 11Nov2021, the patient experienced headache, lymph node swelling, aches in neck and left arm-pit and general 'grogginess'. The events headache, lymph node swelling, aches in neck and left arm-pit and general 'grogginess' did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events headache, lymph node swelling, aches in neck and left arm-pit and general 'grogginess'. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, lymph node swelling, aches in neck and left arm-pit and general 'grogginess' was resolving at the time of this report.
Blisters formed around the injection site. The blisters "broke open" after about 48 hours. I was left with an open wound that would not heal. It took 8 days before the wound started to heal. I am left with a darkly pigment, flat scar.
Chills at 8PM, inability to get warm enough. Fever, sweating at 4AM. Nausea at 4AM. General Weakness 8PM until noon the following day.
administered past the 30 day refrigeration time; administered past the 30 day refrigeration time; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered past the 30 day refrigeration time) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008C21A and 047B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered past the 30 day refrigeration time). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered past the 30 day refrigeration time) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Per reporter, some doses of the Moderna COVID Vaccine had been administered past the 30-day refrigeration time, with temperature fluctuations between 42-43 degrees Fahrenheit.  No treatment medications were reported.
Case number PHEH2013US021239 is an initial spontaneous report received from a registered nurse on 09 OCT 2013 with a follow up received on 05 NOV 2013. This report refers to a 16-year-old female patient. She was given only MenCYW-135 liquid component of MENVEO (batch number: M12102) intramuscularly in to the left deltoid on 01 OCT 2013. No adverse event was reported following this administration error (inappropriate preparation of medication). Follow-up received from the nurse on 05 NOV 2013. Updated patient demographics and site and date of administration of MENVEO.
5days p/vax pt exp vomiting, no stool; 7/28 inc vomiting (currant jelly stool),w/ large blood; adm to hosp; ,barium enema reduction (unsuccessful); laparoscopic surgery to correct classic intussusception; still recovering
Patient had nerve pain in right leg and tingling in feet. Over the last 12 days it has progressed to "partial paralysis", hard time with mobility
She ran a fever and vomiting (3 or 4 separate vomits between 4 am and 10 am). She was sent home from daycare that morning. The highest fever we recorded was 101 (note, that was after she had been given Tylenol). She was very tired that day and took a long nap (she usually does not nap). We called the pediatrician's office/pediatric nurse line for advice. We were not sure if this was typical for a vaccine reaction or if she might have coincidentally picked up another virus. The next day she was completely back to normal.
At 12am-1am that night, patient states suddent onset of tightness and spasms in the muscles of the neck, dizziness, and increased heart rate. The muscle spasms in the neck caused her head to continuously twitch. She states that these symptoms were reoccurring for "the remainder of the night". Patient called the pharmacy ~2pm on Sunday 12/06/20 to report reaction at which time she stated she is still experiencing soreness and tightness in the neck muscles. Patient did not seek medical attention or take any over-the-counter medications to treat her reaction. I recommended she reach out to her primary care provider to let them know of her reaction and to seek medical attention if severe symptoms come back.
5 Doses administered past the expiration date/5 doses were administered (all booster doses of 0.25 ml) from expired vials; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (5 Doses administered past the expiration date/5 doses were administered (all booster doses of 0.25 ml) from expired vials) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 27-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (5 Doses administered past the expiration date/5 doses were administered (all booster doses of 0.25 ml) from expired vials). On 27-Oct-2021, EXPIRED PRODUCT ADMINISTERED (5 Doses administered past the expiration date/5 doses were administered (all booster doses of 0.25 ml) from expired vials) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications provided. No treatment medications provided.  Vials were taken out of freezer on 27 Oct 2021. Vials were thawed and administered on the same day. Vials were stored properly, no temperature excursions involved.   This case was linked to MOD-2021-380859, MOD-2021-380858, MOD-2021-380834, MOD-2021-380860 (Patient Link).
mom stated pt started screaming w/ pain @ 7PM, t101.8 w/in 10 mins t103.8 contacted MD; advised to give APAP; pt woke about every 15mins crying;
A report has been received from a Health Professional concerning a 12 year old, Male subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT started on 13-Dec-2013. It was reported that patient had received expired FLUMIST QUADRIVALENT which started on 13-Dec-2013. The outcome of the event of received expired FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious.
sore arm; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm) and HEADACHE (headache). At the time of the report, PAIN IN EXTREMITY (sore arm) and HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
felt like he was fainting; felt like his heart was coming out of his chest; a cyst in his neck on the left side; The caller received the vaccine in his left shoulder and there are 2 bumps that show up in the x-ray; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570). The reporter is the patient.  A 53 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 02Dec2021 (Lot number: 33030BD) at the age of 53 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "gets sick from pollen" (unspecified if ongoing), notes: gets sick from pollen. There were no concomitant medications. Vaccination history included: Covid-19 vaccine (Dose: 1, Manufacturer unknown), for COVID-19 immunization. The following information was reported: SYNCOPE (medically significant), outcome "unknown", described as "felt like he was fainting"; CARDIAC DISORDER (non-serious), outcome "unknown", described as "felt like his heart was coming out of his chest"; CYST (non-serious), outcome "unknown", described as "a cyst in his neck on the left side"; SWELLING (non-serious), outcome "unknown", described as "The caller received the vaccine in his left shoulder and there are 2 bumps that show up in the x-ray". The events "felt like he was fainting", "felt like his heart was coming out of his chest" and "a cyst in his neck on the left side" were evaluated at the emergency room visit. The patient underwent the following laboratory tests and procedures: blood test: unknown results; investigation: unknown results; x-ray: there are 2 bumps/ 2 small cysts. Clinical course: Clinical course: On Dec the patient had the second vaccine and can't really remember the day but it was in Dec. The patient had a really bad side effect, it didn't do that with the first one but the second one had him on the bed and felt like his heart was coming out of his chest and had to be taken to the hospital and the doctor said it was a side effect of the Covid 19 vaccine. The caller had to go to the emergency room.  The patient had the vaccine in his left shoulder and it created a cyst in his neck on the left side. They did an x-ray and it showed 2 small cysts, the said cysts but its called something else. Anytime the caller touches that part it was like he was going to faint. There was an artery on that side of the neck and the caller felt like he was fainting and it was really bad and he had to go to the hospital. They did an x-ray to his neck and blood work and a lot of tests.   No follow-up attempts are possible. No further information is expected.
Patient experienced dizziness, blurry vision, and ringing of the ear around 5 minutes after the vaccination. Paramedics were called to the pharmacy to assist the patient and they monitored her vital signs.  She was in their care.
Patient presented to the ED after being found down outside. Initially hypotensive, was intubated in ED. Required increasing pressor support. Found to have profound anion gap metabolic acidosis with lactate peaking at >27. Initial workup also significant for WBC 40s, AKI with Cr peak at 2.5. Transaminitis likely 2/2 shock liver. Toxicologic workup was negative for alcohol, Tylenol, salicylates, urine drug screen. Blood cultures grew S. hominis. Other infectious workup including covid, hepatitis, hiv, rocky mountain spotted fever, respiratory panel, GI PCR, all negative. Also found to have a PE which was removed via thrombectomy. Developed DIC requiring multiple transfusions of cryo, FFP, and RBCs. Condition improved slowly with lactate downtrending currently and pressor requirement weaning.
sore arm, woke up at 10:10 with severe stomach upset, and gas. took some tums and laid back down, then got up a few minutes later with nausea, tried to vomit however felt dissy/ fainted. got back in bed with fever/ chills, layed down for a few minutes and felt better. entire episode lasted about 20 minutes. woke up the next morning with nausea, and general tired feeling. this lasted for about 12 more hours.
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 10-Mar-2021, PAIN IN EXTREMITY (sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Erythema and warmth on left thigh about 5 X 10cm. No induration. Treated with Benadryl and ibuprofen.